These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9208095)

  • 41. Effects of imidazoline receptor ligands on monoamine synthesis in the rat brain in vivo.
    Sastre-Coll A; Esteban S; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Jul; 360(1):50-62. PubMed ID: 10463334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Analysis of the receptor involved in the central hypotensive effect of rilmenidine and moxonidine.
    Bock C; Niederhoffer N; Szabo B
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Apr; 359(4):262-71. PubMed ID: 10344524
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why imidazoline receptor modulator in the treatment of hypertension?
    Schäfer SG; Kaan EC; Christen MO; Löw-Kröger A; Mest HJ; Molderings GJ
    Ann N Y Acad Sci; 1995 Jul; 763():659-72. PubMed ID: 7677385
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and biological evaluation of pyrrolinic isosteres of rilmenidine. Discovery of cis-/trans-dicyclopropylmethyl-(4,5-dimethyl-4,5-dihydro-3H-pyrrol-2-yl)-amine (LNP 509), an I1 imidazoline receptor selective ligand with hypotensive activity.
    Schann S; Bruban V; Pompermayer K; Feldman J; Pfeiffer B; Renard P; Scalbert E; Bousquet P; Ehrhardt JD
    J Med Chem; 2001 May; 44(10):1588-93. PubMed ID: 11334568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structure-activity relationships in 1,4-benzodioxan-related compounds. 6. Role of the dioxane unit on selectivity for alpha(1)-adrenoreceptor subtypes.
    Quaglia W; Pigini M; Piergentili A; Giannella M; Marucci G; Poggesi E; Leonardi A; Melchiorre C
    J Med Chem; 1999 Jul; 42(15):2961-8. PubMed ID: 10425105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of amine oxidase activity by derivatives that recognize imidazoline I2 sites.
    Carpéné C; Collon P; Remaury A; Cordi A; Hudson A; Nutt D; Lafontan M
    J Pharmacol Exp Ther; 1995 Feb; 272(2):681-8. PubMed ID: 7853182
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of imidazoline derivatives on cholinergic motility in guinea-pig ileum: involvement of presynaptic alpha2-adrenoceptors or imidazoline receptors?
    Colucci R; Blandizzi C; Carignani D; Placanica G; Lazzeri G; Del Tacca M
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):682-91. PubMed ID: 9686946
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig.
    Wikberg JE; Uhlén S; Chhajlani V
    Eur J Pharmacol; 1991 Feb; 193(3):335-40. PubMed ID: 1675995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Presynaptic imidazoline receptors and alpha 2-adrenoceptors in the human heart: discrimination by clonidine and moxonidine.
    Likungu J; Molderings GJ; Göthert M
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):689-92. PubMed ID: 8938671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conformationally defined adrenergic agents. 2. Catechol imidazoline derivatives: biological effects at alpha 1 and alpha 2 adrenergic receptors.
    DeBernardis JF; Kyncl JJ; Basha FZ; Arendsen DL; Martin YC; Winn M; Kerkman DJ
    J Med Chem; 1986 Apr; 29(4):463-7. PubMed ID: 2870187
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites.
    Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO
    J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
    Gentili F; Cardinaletti C; Carrieri A; Ghelfi F; Mattioli L; Perfumi M; Vesprini C; Pigini M
    Eur J Pharmacol; 2006 Dec; 553(1-3):73-81. PubMed ID: 17081513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. alpha(2) Adrenoceptor agonists as potential analgesic agents. 2. Discovery of 4-(4-Imidazo)-1,3-dimethyl-6,7-dihydrothianaphthene [corrected] as a high-affinity ligand for the alpha(2D) adrenergic receptor.
    Ross TM; Jetter MC; McDonnell ME; Boyd RE; Connelly CD; Martinez RP; Lewis MA; Codd EE; Raffa RB; Reitz AB
    J Med Chem; 2000 Mar; 43(5):765-8. PubMed ID: 10715142
    [No Abstract]   [Full Text] [Related]  

  • 56. 2-(4,5-dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I(2) imidazoline receptor ligands.
    Saczewski F; Hudson AL; Tyacke RJ; Nutt DJ; Man J; Tabin P; Saczewski J
    Eur J Pharm Sci; 2003 Oct; 20(2):201-8. PubMed ID: 14550886
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Are imidazoline receptors involved in sympathetic neurotransmission in rat vas deferens?
    Avellar MC; Markus RP
    Gen Pharmacol; 1996 Oct; 27(7):1273-8. PubMed ID: 8981080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Imidazoline receptors in rat liver cells: a novel receptor or a subtype of alpha 2-adrenoceptors?
    Zonnenchein R; Diamant S; Atlas D
    Eur J Pharmacol; 1990 Nov; 190(1-2):203-15. PubMed ID: 1981751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preparation, structure and affinity for imidazoline I2 receptors and alpha2-adrenoceptors of 1-[(4,5-dihydroimidazolidin-2-yl)imino]indan-2-ols.
    Kornicka A; Saczewski F; Tyacke RJ; Hudson AL; Nutt DJ
    Acta Pol Pharm; 2005; 62(6):497-502. PubMed ID: 16583991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.